Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early IV Magnesium Sulfate for Cerebral Vasospasm in Traumatic SAH
NCT07252505Phase 1Not yet recruiting
- Sponsor
- Assiut University
- Start
- Nov 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial in subarachnoid hemorrhage (SAH) comparing Magnesium Sulfate with Placebo (2 arms). Primary endpoint: Incidence and Severity of Cerebral Vasospasm at Day 7. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT07252505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07252505.